{"id":"W2023859994","doi":"10.1007/s13300-012-0013-8","title":"Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)","year":2012,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"F. Hoffmann-La Roche","keywords":"Sitagliptin; Medicine; Placebo; Metformin; Internal medicine; Sitagliptin Phosphate; Clinical endpoint; Gastroenterology; Diabetes mellitus; Type 2 diabetes; Randomized controlled trial; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000447934,0.000258314,0.0005708796,0.0001234944,0.00007234207,0.0000134185,0.00009252183,0.00009089933,0.0001733905],"category_scores_gemma":[0.0001225197,0.0002058341,0.0001575606,0.0002015773,0.00009462101,0.0001319562,0.00003970172,0.00006902263,0.00002387014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004258007,"about_ca_system_score_gemma":0.00002092542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002085446,"about_ca_topic_score_gemma":6.011277e-7,"domain_scores_codex":[0.9985336,0.00004756233,0.0003578641,0.0002517909,0.0001950375,0.0006141401],"domain_scores_gemma":[0.9987419,0.0004757889,0.0001405742,0.0003641955,0.00008691131,0.000190667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1195828,0.004976739,0.141864,0.0006468797,0.006240793,0.000001296413,0.001216114,0.000004481414,0.03115904,0.005908486,0.006702619,0.6816967],"study_design_scores_gemma":[0.3747845,0.01723647,0.1089303,0.0002472994,0.001618644,1.281618e-7,0.0001948544,0.0001253434,0.1046555,0.0003073143,0.3910507,0.0008489158],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734017,0.02204691,0.000006574674,0.0002879291,0.0008951866,0.002131567,0.00002453139,0.0000624089,0.001143245],"genre_scores_gemma":[0.9947937,0.00282536,0.0009601597,0.0002656555,0.0003658825,0.0001577643,0.0001398663,0.00005077438,0.0004408507],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6808478,"threshold_uncertainty_score":0.8393672,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04398356113229868,"score_gpt":0.3092227144635877,"score_spread":0.265239153331289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}